IndiaRF completed the acquisition of a majority stake in Ivy Health and Life Sciences for $64m.

IndiaRF, an investment company, completed the acquisition of a majority stake in Ivy Health and Life Sciences, a health care company, for $64m. “Post Covid, there's significant emphasis on providing localised healthcare in the form of multi-speciality regional hospital networks. Ivy has demonstrated its prowess as a regional healthcare provider catering to all segments by providing quality medical services at affordable prices,” Shantanu Nalavadi, IndiaRF Managing Director.